Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Type of study
Language
Publication year range
1.
Stroke ; 33(9): 2304-10, 2002 Sep.
Article in English | MEDLINE | ID: mdl-12215603

ABSTRACT

BACKGROUND AND PURPOSE: Perinatal hypoxia-ischemia is a major cause of neonatal morbidity and mortality. Until now no established neuroprotective intervention after perinatal hypoxia-ischemia has been available. The delay in cell death after perinatal hypoxia-ischemia creates possibilities for therapeutic intervention after the initial insult. Excessive nitric oxide and reactive oxygen species generated on hypoxia-ischemia and reperfusion play a key role in the neurotoxic cascade. The present study examines the neuroprotective properties of neuronal and inducible but not endothelial nitric oxide synthase inhibition by 2-iminobiotin in a piglet model of perinatal hypoxia-ischemia. METHODS: Twenty-three newborn piglets were subjected to 60 minutes of hypoxia-ischemia, followed by 24 hours of reperfusion and reoxygenation. Five additional piglets served as sham-operated controls. On reperfusion, piglets were randomly treated with either vehicle (n=12) or 2-iminobiotin (n=11). At 24 hours after hypoxia-ischemia, the cerebral energy state, presence of vasogenic edema, amount of apparently normal neuronal cells, caspase-3 activity, amount of terminal deoxynucleotidyl transferase-mediated dUTP-biotin in situ nick end labeling (TUNEL)-positive cells, and degree of tyrosine nitration were assessed. RESULTS: A 90% improvement in cerebral energy state, 90% reduction in vasogenic edema, and 60% to 80% reduction in apoptosis-related neuronal cell death were demonstrated in 2-iminobiotin-treated piglets at 24 hours after hypoxia- ischemia. A significant reduction in tyrosine nitration in the cerebral cortex was observed in 2-iminobiotin-treated piglets, indicating decreased formation of reactive nitrogen species. CONCLUSIONS: Simultaneous and selective inhibition of neuronal and inducible nitric oxide synthase by 2-iminobiotin is a promising strategy for neuroprotection after perinatal hypoxia-ischemia.


Subject(s)
Biotin/analogs & derivatives , Biotin/pharmacology , Hypoxia-Ischemia, Brain/drug therapy , Neuroprotective Agents/pharmacology , Nitric Oxide Synthase/antagonists & inhibitors , Reperfusion Injury/prevention & control , Animals , Animals, Newborn , Apoptosis/drug effects , Brain/blood supply , Brain/drug effects , Brain/pathology , Brain/physiopathology , Brain Edema/etiology , Brain Edema/pathology , Brain Edema/prevention & control , Caspase 3 , Caspases/metabolism , Disease Models, Animal , Energy Metabolism/drug effects , Enzyme Inhibitors/pharmacology , Hypoxia-Ischemia, Brain/complications , Hypoxia-Ischemia, Brain/physiopathology , Immunohistochemistry , In Situ Nick-End Labeling , Magnetic Resonance Spectroscopy , Reperfusion Injury/etiology , Reperfusion Injury/pathology , Survival Rate , Swine , Treatment Outcome , Tyrosine/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...